BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

991 related articles for article (PubMed ID: 31055910)

  • 21. Arachidonic acid affects biofilm formation and PGE2 level in Candida albicans and non-albicans species in presence of subinhibitory concentration of fluconazole and terbinafine.
    Mishra NN; Ali S; Shukla PK
    Braz J Infect Dis; 2014; 18(3):287-93. PubMed ID: 24389279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of coumarin against Candida albicans biofilms.
    Xu K; Wang JL; Chu MP; Jia C
    J Mycol Med; 2019 Apr; 29(1):28-34. PubMed ID: 30606640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against
    Raut JS; Bansode BS; Jadhav AK; Karuppayil SM
    J Microbiol Biotechnol; 2017 Apr; 27(4):685-693. PubMed ID: 28138121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals.
    Watamoto T; Samaranayake LP; Egusa H; Yatani H; Seneviratne CJ
    J Med Microbiol; 2011 Sep; 60(Pt 9):1241-1247. PubMed ID: 21474609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
    Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y
    Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.
    Nobile CJ; Fox EP; Hartooni N; Mitchell KF; Hnisz D; Andes DR; Kuchler K; Johnson AD
    mBio; 2014 Jun; 5(3):e01201-14. PubMed ID: 24917598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans.
    Hsu CC; Lai WL; Chuang KC; Lee MH; Tsai YC
    Med Mycol; 2013 Jul; 51(5):473-82. PubMed ID: 23210679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of fluconazole resistance-associated genes in biofilm from 23 clinical isolates of Candida albicans.
    Shi C; Liu J; Li W; Zhao Y; Meng L; Xiang M
    Braz J Microbiol; 2019 Jan; 50(1):157-163. PubMed ID: 30617866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory activity of hinokitiol against biofilm formation in fluconazole-resistant Candida species.
    Kim DJ; Lee MW; Choi JS; Lee SG; Park JY; Kim SW
    PLoS One; 2017; 12(2):e0171244. PubMed ID: 28152096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between allicin and fluconazole in Candida albicans biofilm inhibition and in suppression of HWP1 gene expression.
    Khodavandi A; Harmal NS; Alizadeh F; Scully OJ; Sidik SM; Othman F; Sekawi Z; Ng KP; Chong PP
    Phytomedicine; 2011 Dec; 19(1):56-63. PubMed ID: 21924600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Anticancer Agent 3,3'-Diindolylmethane Inhibits Multispecies Biofilm Formation by Acne-Causing Bacteria and Candida albicans.
    Kim YG; Lee JH; Park S; Lee J
    Microbiol Spectr; 2022 Feb; 10(1):e0205621. PubMed ID: 35107361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
    Bruzual I; Riggle P; Hadley S; Kumamoto CA
    J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative Abundances of Candida albicans and Candida glabrata in
    Olson ML; Jayaraman A; Kao KC
    Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422
    [No Abstract]   [Full Text] [Related]  

  • 34. Zerumbone inhibits
    Shin DS; Eom YB
    Can J Microbiol; 2019 Oct; 65(10):713-721. PubMed ID: 31158320
    [No Abstract]   [Full Text] [Related]  

  • 35. Bioactive triterpenoids from Solanum torvum fruits with antifungal, resistance modulatory and anti-biofilm formation activities against fluconazole-resistant candida albicans strains.
    Harley BK; Neglo D; Tawiah P; Pipim MA; Mireku-Gyimah NA; Tettey CO; Amengor CD; Fleischer TC; Waikhom SD
    PLoS One; 2021; 16(12):e0260956. PubMed ID: 34962953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudomonas aeruginosa lipopolysaccharide inhibits Candida albicans hyphae formation and alters gene expression during biofilm development.
    Bandara HM; K Cheung BP; Watt RM; Jin LJ; Samaranayake LP
    Mol Oral Microbiol; 2013 Feb; 28(1):54-69. PubMed ID: 23194472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiofilm activity of lawsone against polymicrobial enterohemorrhagic Escherichia coli O157:H7 and Candida albicans by suppression of curli production and hyphal growth.
    Lee JH; Kim YG; Lee J
    Phytomedicine; 2024 Feb; 124():155306. PubMed ID: 38176270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.
    Sun L; Liao K; Wang D
    PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histatin 5 and human lactoferrin inhibit biofilm formation of a fluconazole resistant Candida albicans clinical isolate.
    Curvelo JAR; Moraes DC; Anjos CAD; Portela MB; Soares RMA
    An Acad Bras Cienc; 2019; 91(1):e20180045. PubMed ID: 30994755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of biofilm- and hyphal- development, two virulent features of Candida albicans by secondary metabolites of an endophytic fungus Alternaria tenuissima having broad spectrum antifungal potential.
    Chatterjee S; Ghosh R; Mandal NC
    Microbiol Res; 2020 Feb; 232():126386. PubMed ID: 31816593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.